TORONTO, ON / ACCESSWIRE / January 7, 2025 / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two distinguished leaders to its team. Dr. Dave Garman has been ...

Experienced pharmacy provider now bringing expert dispensing and personalized support to PACE participants MORTON GROVE, ILLINOIS / ACCESSWIRE / January 7, 2025 / OnePoint Patient Care, a leading ...

New partnership will deliver convenient, at-home X-ray and ultrasound services to over 60,000 Medicare Advantage members in Illinois, Missouri, Ohio, Kentucky and Indiana SPARKS, MD and ST. LOUIS, MO ...

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications ...

SOUTHLAKE, TX and HOUSTON, TX / ACCESSWIRE / January 7, 2025 / Allied OMS, one of the country's premier management services organizations (MSO) specializing in oral and maxillofacial surgery, is ...

Ekol Hospitals leads in shaping the future of Obesity TreatmentEkol International Hospitals, a leading authority in obesity treatment in Türkiye, underscores the urgent need for a holistic and ...

Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros ...

TAMPA, FLORIDA / ACCESSWIRE / January 7, 2025 / Client experience survey results from 1,914 physicians, clinicians, and administrative staff rate Surgical Information Systems (SIS) first among ...

The 12,000 sq ft multispecialty clinic provides family medicine, specialty care like internal medicine, urology and interventional cardiology, and diagnostic services including lab and imaging, all in ...

Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...

Carterra Inc., the world leader in enabling high-throughput biology, announced today that it has sold and shipped its first Carterra Ultra™ biosensor platform. Announced in September 2024, the Ultra ...